Temasek led a USD80m Series B for Mojia Biotech, a China-based bio-manufacturing company with a focus on sustainable development and carbon neutrality, with participation from LYZZ Capital and Sento Investment, and follow-on from Bits x Bites, Asia Green Fund and other investors. Read more